The Famous $5 Million Discarded Molecule

Bought for $5million. IPO-ed at $4 billion. Miracle by a young 24-year old.

He is our hero.

That was CNS

 The famous 5-HT6 receptor agonist molecule discarded by big pharma, purchased for $5M and IPO'ed at $3B.

This is ONCO

As oncology experts we want to discover our hidden gem in the Oncology Hematology (OncoHeme) arena .

Our Network

Using our immense network of clinical trial specialists, we will develop that molecule through proof of concept.

To be continued…

But feel free to express interest over an email.